Home NDC 53002-0524 NDC 53002-0524 - Cyclobenzaprine Hydrochloride This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
Product NDC 53002-0524
Package NDCs from labels 53002-0524-3, 53002-0524-4, 53002-0524-1, 53002-0524-2, 53002-0524-5
Manufacturer RPK Pharmaceuticals, Inc.
Effective date 2023-07-05
Current FDA listing Not matched in FDA.report NDC product tables FDA-Initiated Inactive NDC Indexing# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 53002-0524-1 Cyclobenzaprine Hydrochloride 5 in 1 BOTTLE TABLET, FILM COATED 5 3 53002-0524-2 Cyclobenzaprine Hydrochloride 10 in 1 BOTTLE TABLET, FILM COATED 10 3 53002-0524-3 Cyclobenzaprine Hydrochloride 15 in 1 BOTTLE TABLET, FILM COATED 15 3 53002-0524-4 Cyclobenzaprine Hydrochloride 20 in 1 BOTTLE TABLET, FILM COATED 20 3 53002-0524-5 Cyclobenzaprine Hydrochloride 30 in 1 BOTTLE TABLET, FILM COATED 30 3
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 53002-0524 CYCLOBENZAPRINE HYDROCHLORIDE TABLET, FILM COATED [RPK PHARMACEUTICALS, INC.] 3 5 package rows 20230707_0923e84f-5967-4737-ae9d-10a0edeaa937.zip